|
HLA Desensitizing Ups Survival in Kidney Transplant - MedPage Today |
MedPage Today
Patients who underwent desensitization had an eight-year survival of 80.6%, compared with 30.5% for patients on dialysis and 49.1% for patients on dialysis and wait-listed for transplantation (P<0.001 for both comparisons). The results suggest that
|
|
Amgen Beats, Updates Outlook - Zacks.com |
Zacks.com
The decline reflected the impact of the implementation of the ESRD bundling strategy earlier this year. We expect dose utilization to continue declining in 2011. The potential implementation of label changes and reimbursement changes proposed by the
|
New Risk for Sudden Death in Dialysis Patients - MedPage Today |
MedPage Today
"Longitudinal assessment of homoarginine may be useful for risk monitoring of dialysis patients," they wrote. "Beyond this, homoarginine may become a promising novel target for therapeutic interventions in populations with high incidences of heart
|
Amgen 2Q Profit Beats on Record Product Sales - Fox Business |
Fox Business
based maker of human therapeutics in support of cancer, nephrology and inflammation, posted net income of $1.17 billion, or $1.25 a share, compared with $1.2 billion, or $1.25 a share, in the same quarter last year. Excluding special items, the company
|
Blood Pressure Drop During Dialysis May Raise Clot Risk - U.S. News World Report |
U.S. News & World Report
"This is just one more good reason to continue these efforts." The study is published in the July 29 online edition of the Journal of the American Society of Nephrology. The National Kidney Foundation has more about dialysis.
Potentially lethal clotting linked to blood pressure drop during dialysis Scope (blog)
Low blood pressure during dialysis increases risk of clots, according to
|
|
|
|
<< Start < Prev 771 772 773 774 775 776 777 778 779 780 Next > End >>
|
Page 776 of 2630 |